vs
Side-by-side financial comparison of Dream Finders Homes, Inc. (DFH) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Dream Finders Homes, Inc. is the larger business by last-quarter revenue ($1.2B vs $1.1B, roughly 1.1× PERRIGO Co plc). Dream Finders Homes, Inc. runs the higher net margin — 4.8% vs -127.8%, a 132.7% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -22.3%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $136.0M). Over the past eight quarters, Dream Finders Homes, Inc.'s revenue compounded faster (21.0% CAGR vs 1.3%).
Dream Finders Homes, Inc. is a U.S. homebuilding firm that constructs and sells entry-level to luxury residential properties, including single-family homes and townhomes, across high-growth domestic markets. It also provides mortgage, title insurance and home warranty services for homebuyers.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
DFH vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.1B |
| Net Profit | $58.8M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 6.4% | -116.0% |
| Net Margin | 4.8% | -127.8% |
| Revenue YoY | -22.3% | -2.5% |
| Net Profit YoY | -54.9% | -3093.9% |
| EPS (diluted) | $0.57 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $969.8M | $1.0B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $989.9M | $1.0B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $827.8M | $1.1B |
| Q4 25 | $58.8M | $-1.4B | ||
| Q3 25 | $47.0M | $7.5M | ||
| Q2 25 | $56.6M | $-8.4M | ||
| Q1 25 | $54.9M | $-6.4M | ||
| Q4 24 | $130.5M | $-44.4M | ||
| Q3 24 | $70.7M | $-21.0M | ||
| Q2 24 | $80.9M | $-108.4M | ||
| Q1 24 | $54.5M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | 19.2% | 37.0% | ||
| Q1 24 | 18.0% | 33.1% |
| Q4 25 | 6.4% | -116.0% | ||
| Q3 25 | 6.3% | 7.0% | ||
| Q2 25 | 6.4% | 4.3% | ||
| Q1 25 | 7.2% | 4.5% | ||
| Q4 24 | 10.8% | 10.0% | ||
| Q3 24 | 9.2% | 7.4% | ||
| Q2 24 | 10.0% | -2.5% | ||
| Q1 24 | 8.6% | -5.1% |
| Q4 25 | 4.8% | -127.8% | ||
| Q3 25 | 4.8% | 0.7% | ||
| Q2 25 | 4.9% | -0.8% | ||
| Q1 25 | 5.5% | -0.6% | ||
| Q4 24 | 8.4% | -3.9% | ||
| Q3 24 | 7.0% | -1.9% | ||
| Q2 24 | 7.7% | -10.2% | ||
| Q1 24 | 6.6% | 0.2% |
| Q4 25 | $0.57 | $-10.23 | ||
| Q3 25 | $0.47 | $0.05 | ||
| Q2 25 | $0.56 | $-0.06 | ||
| Q1 25 | $0.54 | $-0.05 | ||
| Q4 24 | $1.28 | $-0.32 | ||
| Q3 24 | $0.70 | $-0.15 | ||
| Q2 24 | $0.81 | $-0.79 | ||
| Q1 24 | $0.55 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $234.8M | — |
| Total DebtLower is stronger | $1.6B | — |
| Stockholders' EquityBook value | $1.4B | $2.9B |
| Total Assets | $3.7B | $8.5B |
| Debt / EquityLower = less leverage | 1.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $234.8M | — | ||
| Q3 25 | $251.0M | $432.1M | ||
| Q2 25 | $210.3M | $454.2M | ||
| Q1 25 | $297.5M | $409.9M | ||
| Q4 24 | $274.4M | $558.8M | ||
| Q3 24 | $204.9M | $1.5B | ||
| Q2 24 | $274.8M | $542.8M | ||
| Q1 24 | $239.4M | $658.5M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.4B | $2.9B | ||
| Q3 25 | $1.4B | $4.4B | ||
| Q2 25 | $1.3B | $4.5B | ||
| Q1 25 | $1.3B | $4.4B | ||
| Q4 24 | $1.2B | $4.3B | ||
| Q3 24 | $1.1B | $4.6B | ||
| Q2 24 | $1.0B | $4.5B | ||
| Q1 24 | $968.7M | $4.7B |
| Q4 25 | $3.7B | $8.5B | ||
| Q3 25 | $3.8B | $10.1B | ||
| Q2 25 | $3.7B | $10.1B | ||
| Q1 25 | $3.5B | $9.8B | ||
| Q4 24 | $3.3B | $9.6B | ||
| Q3 24 | $3.3B | $11.2B | ||
| Q2 24 | $3.0B | $10.4B | ||
| Q1 24 | $2.7B | $10.6B |
| Q4 25 | 1.13× | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $143.6M | $175.4M |
| Free Cash FlowOCF − Capex | $136.0M | $148.6M |
| FCF MarginFCF / Revenue | 11.2% | 13.4% |
| Capex IntensityCapex / Revenue | 0.6% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-126.4M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $143.6M | $175.4M | ||
| Q3 25 | $-131.0M | $51.7M | ||
| Q2 25 | $-68.5M | $75.9M | ||
| Q1 25 | $-44.7M | $-64.5M | ||
| Q4 24 | $306.5M | $312.6M | ||
| Q3 24 | $-205.0M | $42.2M | ||
| Q2 24 | $-110.6M | $9.5M | ||
| Q1 24 | $-247.5M | $-1.4M |
| Q4 25 | $136.0M | $148.6M | ||
| Q3 25 | $-135.7M | $29.8M | ||
| Q2 25 | $-78.8M | $56.7M | ||
| Q1 25 | $-47.9M | $-90.0M | ||
| Q4 24 | $302.6M | $274.9M | ||
| Q3 24 | $-222.5M | $15.1M | ||
| Q2 24 | $-112.4M | $-18.9M | ||
| Q1 24 | $-249.6M | $-26.5M |
| Q4 25 | 11.2% | 13.4% | ||
| Q3 25 | -14.0% | 2.9% | ||
| Q2 25 | -6.8% | 5.4% | ||
| Q1 25 | -4.8% | -8.6% | ||
| Q4 24 | 19.4% | 24.2% | ||
| Q3 24 | -22.1% | 1.4% | ||
| Q2 24 | -10.6% | -1.8% | ||
| Q1 24 | -30.2% | -2.4% |
| Q4 25 | 0.6% | 2.4% | ||
| Q3 25 | 0.5% | 2.1% | ||
| Q2 25 | 0.9% | 1.8% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 0.3% | 3.3% | ||
| Q3 24 | 1.7% | 2.5% | ||
| Q2 24 | 0.2% | 2.7% | ||
| Q1 24 | 0.3% | 2.3% |
| Q4 25 | 2.44× | — | ||
| Q3 25 | -2.79× | 6.89× | ||
| Q2 25 | -1.21× | — | ||
| Q1 25 | -0.81× | — | ||
| Q4 24 | 2.35× | — | ||
| Q3 24 | -2.90× | — | ||
| Q2 24 | -1.37× | — | ||
| Q1 24 | -4.54× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFH
| Midwest Segment | $454.2M | 37% |
| Southeast Segment | $397.5M | 33% |
| Mid Atlantic Segment | $307.3M | 25% |
| Financial Services Segment | $53.7M | 4% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
